Published in Cancer Res on August 30, 2016
Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin? Trends Cancer (2017) 0.75
RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression. Cancer Res (2017) 0.75
Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep (2017) 0.75
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Java Treeview--extensible visualization of microarray data. Bioinformatics (2004) 24.12
Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res (2008) 10.66
Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res (2001) 3.45
Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res (2008) 3.39
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst (2009) 2.53
Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat Genet (1999) 2.31
Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate (2005) 2.18
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients. Prostate (2010) 2.05
Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene (2004) 2.02
Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol (2010) 2.00
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes. Eur Urol (2015) 1.80
Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol (2003) 1.61
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol (2001) 1.60
African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer (2006) 1.52
A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer. Cancer Res (2013) 1.39
Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res (2011) 1.37
Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett (2006) 1.35
Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol Biomarkers Prev (2013) 1.32
Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci U S A (1997) 1.28
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol (1999) 1.27
Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res (2006) 1.24
Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol (2004) 1.10
Trefoil factor 3 is overexpressed in human prostate cancer. Prostate (2004) 1.09
FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling. Clin Cancer Res (2011) 1.07
Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men. Int J Mol Sci (2013) 1.03
The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Prostate (2006) 1.00
High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes Chromosomes Cancer (2006) 0.97
Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer. Int J Cancer (2013) 0.95
Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivo. Mol Cell Endocrinol (2003) 0.94
Elevated caveolin-1 levels in African-American versus white-American prostate cancer. Clin Cancer Res (2000) 0.89
Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis. Oncotarget (2015) 0.86
Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis. J Clin Invest (2015) 0.86
Predominance of ERG-negative high-grade prostate cancers in African American men. Mol Clin Oncol (2014) 0.85
The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma. Virchows Arch (2011) 0.82
Ex vivo four-dimensional lung cancer model mimics metastasis. Ann Thorac Surg (2015) 0.77